
About BioForce Nanosciences
BioForce Nanosciences is a publicly listed company based in Ames (United States) founded in 1999. Nanotech instruments and consumables are developed for life sciences. It operates in the Healthcare and Technology sectors. BioForce Nanosciences has raised $3.97 million across 11 funding rounds from investors including NIH SBIR/STTR, National Institute of Biomedical Imaging and Bioengineering and U.S. Department of Defense. BioForce Nanosciences offers products and services including Nano eNabler System, UV Ozone Cleaner, and Surface Patterning Tool. Its focus areas include High Tech, Nanotechnology, Services and Manufacturing Services. Its legal entity is BioForce Nanosciences, Inc. Its competitors include Quanterix, Biocare Medical and BioLife Solutions; 2 of its 3 listed competitors have raised funding.
Company details
BioForce Nanosciences was founded in 1999 and is headquartered in Ames, United States. Nanotech instruments, consumables, and applications are developed and commercialized by the company for life science uses. Products such as the Nano eNabler molecular printing system, UV ozone cleaner known as ProCleaner, and surface patterning tools are offered. These tools support applications including surface patterning, biosensor development, and small-volume biomolecular assays.
- Headquarters Ames, United States
- Stage Public
- SectorsHealthcareTechnology
- Emailβ’β’β’β’β’β’β’β’
- Website bioforcenano.com
- Social LinkedIn X Facebook
- Legal Name Bioforce Nanosciences, Inc.
- Annual Revenue$17.78 K (USD)9as on Dec 31, 2019
- Net Profit-$490.44 K (USD)-4as on Dec 31, 2024
- EBITDA-$66.74 K (USD)-113as on Dec 31, 2018
- Total Equity Funding$3.97M (USD)
in 11 rounds
- Latest Funding Round$300K (USD), Post-IPO
Jun 2008
- InvestorsNIH SBIR/STTR
& 3 more
Products & Services of BioForce Nanosciences
BioForce Nanosciences offers a comprehensive portfolio of products and services, including Nano eNabler System, UV Ozone Cleaner, and Surface Patterning Tool.
System for precise deposition of liquids in life sciences research.
Cleaner that benefits labs by removing contaminants from surfaces.
Tool for depositing materials with high accuracy in scientific applications.
Funding Insights of BioForce Nanosciences
BioForce Nanosciences has successfully raised a total of $3.97M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $300 thousand completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.97M
- Total Rounds 11
- Last Round Post-IPO β $300,000
- First Round $250,000
(Jun 2002)
- Investors Count 4
Latest 10 of 11 funding rounds of BioForce Nanosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2008 | $300,000 | Post-IPO | β | β | β |
| Sep 2007 | $3.45M | Post-IPO | β | β | β |
| Jul 2007 | $200,000 | Grant | β | β | |
| Mar 2006 | $6M | Post-IPO | β | β | β |
| Jun 2005 | $1.42M | Series A | β | β | β |
| Jun 2005 | $547,472 | Series A | β | β | β |
| Jan 2003 | Grant | β | β | ||
| Dec 2002 | Grant | β | β | ||
| Nov 2002 | $2M | Series A | β | β | β |
| Jul 2002 | $500,000 | Grant | β | β |
4 investors in total: 4 institutional.
Investors in BioForce Nanosciences
BioForce Nanosciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH SBIR/STTR, National Institute of Biomedical Imaging and Bioengineering and U.S. Department of Defense.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| sbir.nih.gov | ||||
Research in biomedical imaging and bioengineering is conducted by NIBIB. | nibib.nih.gov | Bethesda, United States | ||
Military forces are provided by the U.S. Department of Defense for national security. | defense.gov | Washington, D.C., United States | ||
| niaid.nih.gov |
Investor details for BioForce Nanosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioForce Nanosciences
2 people are tracked at BioForce Nanosciences (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Kerry Frey | President/COO | Leadership |
Judi Insley | Executive Assistant / Office Manager / Operations Manager | Team |
Complete people profiles for BioForce Nanosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioForce Nanosciences
4 dated milestones of BioForce Nanosciences across 16 years, from founding to its latest funding, stage changes and deals.
- Founded BioForce Nanosciences is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Post-IPO, of $300K.
- IPO Lists on the stock exchange (IPO).
Competitors of BioForce Nanosciences
BioForce Nanosciences has 3 listed competitors in our database, 2 of them funded. They include Quanterix, Biocare Medical and BioLife Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. |
Detailed competitors of BioForce Nanosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioForce Nanosciences
The website of BioForce Nanosciences (bioforcenano.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 14% vs previous month
Websites whose visitors overlap most with BioForce Nanosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| surreynanosystems.com | 83% | View details | |||
| mbraun.com | 67% | 11.8K | #1,997,638 | View details | |
| akronbiotech.com | 42% | 7K | #3,133,382 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as BioForce Nanosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioforce Nanosciences
Complete news archive for BioForce Nanosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioForce Nanosciences
BioForce Nanosciences was founded in 1999 and raised its 1st funding round 3 years after it was founded.
BioForce Nanosciences is headquartered in Ames, United States. It is registered at Ames, Iowa, United States.
BioForce Nanosciences is a funded company, having raised a total of $3.97M across 11 funding rounds to date. The company's 1st funding round was a Grant of $500K, raised on Jun 2002.
Annual revenue of BioForce Nanosciences is $17.78K as on Dec 31, 2019.
BioForce Nanosciences was founded in 1999 and is headquartered in Ames, United States. Nanotech instruments, consumables, and applications are developed and commercialized by the company for life science uses. Products such as the Nano eNabler molecular printing system, UV ozone cleaner known as ProCleaner, and surface patterning tools are offered. These tools support applications including surface patterning, biosensor development, and small-volume biomolecular assays.
BioForce Nanosciences's top competitors include Biocare Medical, Quanterix and BioLife Solutions.
BioForce Nanosciences offers Nano eNabler System, UV Ozone Cleaner, and Surface Patterning Tool.
BioForce Nanosciences has 4 investors. Key investors include NIH SBIR/STTR, National Institute of Biomedical Imaging and Bioengineering, U.S. Department of Defense, and NIAID.
BioForce Nanosciences operates through Bioforce Nanosciences, Inc..
